Research Topic

People are snacking around the clock and, after a year of indulging, are discovering the importance of snacking smarter.

Among the speakers for the October event are former executives from Pfizer and Google, as well as political analysts and economists. 

This week, DSN wants to know what its readers think about whether the federal government should be able to negotiate drug prices for Medicare Part D.

Drug Store News caught up with Yamit Sadok, senior director of marketing at Reserveage parent company Twinlab Consolidation, to discuss its new skin care line.

Pfizer-BioNTech’s COVID-19 vaccine Comirnaty will be marketed for the prevention of COVID-19 in individuals age 16 years old and older. 

Moody’s co-founder and chief economist Mark Zandi told NACDS Total Store Expo attendees that he is optimistic about the economy's near-term prospects over the next 18 to 24 months.

The FDA's approval of Keytruda plus Lenvima provides a first-line treatment of adult patients with advanced renal cell carcinoma, the company said.

Teva won a U.S. appeals court ruling that upheld three patents on its Ajovy migraine drug, though six other patents on the treatment were ruled invalid, according to a report.